China Medical System Holdings Limited

SEHK:867 Rapport sur les actions

Capitalisation boursière : HK$18.2b

China Medical System Holdings Croissance future

Future contrôle des critères 4/6

China Medical System Holdings devrait augmenter ses bénéfices et son chiffre d'affaires de 21.4% et de 14.7% par an respectivement. Le BPA devrait croître de de 21.9% par an. Le rendement des capitaux propres devrait être 15.4% dans 3 ans.

Informations clés

21.4%

Taux de croissance des bénéfices

21.9%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices11.0%
Taux de croissance des recettes14.7%
Rendement futur des capitaux propres15.4%
Couverture par les analystes

Good

Dernière mise à jour18 Dec 2024

Mises à jour récentes de la croissance future

Recent updates

Earnings Tell The Story For China Medical System Holdings Limited (HKG:867) As Its Stock Soars 26%

Sep 30
Earnings Tell The Story For China Medical System Holdings Limited (HKG:867) As Its Stock Soars 26%

Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings

Jul 15
Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

May 22
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

May 03
China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

May 02
We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 19
China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Mar 29
China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

Mar 28
Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Dec 21
China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Is China Medical System Holdings (HKG:867) A Risky Investment?

Dec 04
Is China Medical System Holdings (HKG:867) A Risky Investment?

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Nov 15
If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

Aug 31
China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Aug 30
China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

Aug 07
Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

May 14
We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 26
Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

Feb 05
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

Dec 26
China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Dec 08
If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Sep 14
Is China Medical System Holdings (HKG:867) Using Too Much Debt?

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Aug 25
China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

Aug 15
Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Jul 08
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

May 16
Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Apr 10
Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

Mar 22
China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Feb 09
If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Dec 25
Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Nov 10
Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Sep 25
China Medical System Holdings (HKG:867) Could Easily Take On More Debt

China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Aug 26
China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

Jul 30
Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

Jun 27
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

Prévisions de croissance des bénéfices et des revenus

SEHK:867 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202610,4172,5892,7612,6758
12/31/20258,9382,0392,0361,93810
12/31/20247,8371,7661,9861,88610
6/30/20247,0141,3901,2351,885N/A
3/31/20247,5141,8961,7172,194N/A
12/31/20238,0132,4012,2002,503N/A
9/30/20238,6632,8912,6153,047N/A
6/30/20239,3133,3813,0313,592N/A
3/31/20239,2323,3203,0293,573N/A
12/31/20229,1503,2593,0283,553N/A
9/30/20229,0463,2242,6983,032N/A
6/30/20228,9423,1892,3672,511N/A
3/31/20228,6403,1032,3382,502N/A
12/31/20218,3373,0172,3092,494N/A
9/30/20218,0092,9482,3732,591N/A
6/30/20217,6812,8782,4372,688N/A
3/31/20217,3132,7042,3942,690N/A
12/31/20206,9462,5302,3512,692N/A
9/30/20206,5822,3002,2862,661N/A
6/30/20206,2172,0702,2222,631N/A
3/31/20206,1452,0152,2182,593N/A
12/31/20196,0741,9612,2152,555N/A
9/30/20195,9082,0112,0872,344N/A
6/30/20195,7432,0621,9602,132N/A
3/31/20195,5881,9561,8291,943N/A
12/31/20185,4331,8501,6981,755N/A
9/30/20185,3751,8391,8131,875N/A
6/30/20185,3171,8271,9281,996N/A
3/31/20185,3331,751N/A2,034N/A
12/31/20175,3491,675N/A2,072N/A
9/30/20175,3791,601N/A1,876N/A
6/30/20175,4101,527N/A1,679N/A
3/31/20175,1551,452N/A1,421N/A
12/31/20164,9011,376N/A1,162N/A
9/30/20164,4771,265N/A1,134N/A
6/30/20164,0541,155N/A1,105N/A
3/31/20163,8041,075N/A860N/A
12/31/20153,553996N/A615N/A
9/30/20153,4041,062N/A528N/A
6/30/20153,2551,128N/A441N/A
3/31/20153,1001,087N/A642N/A
12/31/20142,9451,046N/A843N/A
9/30/20142,760890N/A689N/A
6/30/20142,575734N/A535N/A
3/31/20142,412685N/A435N/A
12/31/20132,249636N/A335N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 867 ( 21.4% par an) est supérieure au taux d'épargne ( 2.3% ).

Bénéfices vs marché: Les bénéfices de 867 ( 21.4% par an) devraient croître plus rapidement que le marché Hong Kong ( 11.4% par an).

Croissance élevée des bénéfices: Les bénéfices de 867 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 867 ( 14.7% par an) devrait croître plus rapidement que le marché Hong Kong ( 7.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 867 ( 14.7% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 867 devrait être faible dans 3 ans ( 15.4 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2024/12/27 09:33
Cours de l'action en fin de journée2024/12/27 00:00
Les revenus2024/06/30
Revenus annuels2023/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* exemple pour les titres américains, pour les titres non-américains des formulaires et sources réglementaires équivalents sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). Pour en savoir plus , cliquez ici.

Modèle d'analyse et flocon de neige

Les détails du modèle d'analyse utilisé pour générer ce rapport sont disponibles sur notre page Github. Nous avons également des guides sur la façon d'utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur .

Sources des analystes

China Medical System Holdings Limited est couverte par 34 analystes. 10 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Jessica LiBofA Global Research
Lok Kwan ChiuCCB International Securities Limited
Harry HeChina Galaxy International Securities (Hong Kong)